A Single-Chain Antibody protein with specificity for human IgM will be prepared. The SCA protein will be designed from a variable of the anti-human IgM monoclonal antibody, DA4.4. A gene to synthesize this protein will be constructed and the protein expressed in E. coli. The protein will be folded, purified, and assayed for its binding to human IgM. This protein will be used as a reagent for the purification of human IgM monoclonal antibodies, as a diagnostic reagent for antigen specific IgM, and as a therapeutic in extra corporeal blood filtration for diseases, e.g., cancer, and AIDS. The immobilizations necessary for this protein to perform in these reactions will be developed during Phase II.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM043696-01
Application #
3498457
Study Section
Special Emphasis Panel (SSS (B1))
Project Start
1990-02-01
Project End
1990-08-31
Budget Start
1990-02-01
Budget End
1990-08-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Genex Corporation
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877
Lee, T K; Rollence, M L; Hallberg, P L et al. (1995) Production of engineered IgM-binding single-chain antibodies in Escherichia coli. J Ind Microbiol 14:371-6